Dyax - Advancing Novel Biotherapeutics

Spotlight

Dyax Kicks Off Fundraising Activities in Honor of First Ever HAE Day — A Global Event to Raise Awareness of Hereditary Angioedema Learn More

Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer Learn More

Dyax Corp. to Participate in Upcoming 2012 Healthcare Conferences Learn More

Dyax Corp. Announces Fourth Quarter and Full Year 2011 Financial Results Learn More

See Important Safety Information and Full Prescribing Information including Boxed Warning and Medication Guide on www.KALBITOR.com

technology

At the core of our success is our powerful and proprietary drug discovery technology, phage display Learn More

Dyax Launches HAE Hope, an Online Resource     for Patients with Hereditary Angioedema
Learn More

FINANCIAL ASSISTANCE

Dyax Features Comprehensive Financial Assistance Program On Enhanced Product Website for KALBITOR® (ecallantide)
Learn More